At VRRX, we understand the challenges faced by cancer patients in accessing effective and tolerable therapies. That's why we've developed TumorSimilis, a revolutionary approach to cancer treatment that puts the patient's well-being at the forefront.
Through the use of patented techniques, VRRX is able to grow a patient's tumour in a way that duplicates the inter- and intra-tumoral heterogeneity seen in original cancer patient specimens. This is used by VRRX to identify the best medication for each patient. "Tumoursimilis" is the name of this technique.
Are you interested in developing an AI based cancer solution? Your training data-set defines what your life science AI can do for you. Connect with us to explore out how we can help enhance your understanding of tumor biology with TumorSimilis.
